Rising Demand for Precision Medicine Fuels the Predictive and Presymptomatic Testing Market
The Predictive and Presymptomatic Testing Market is anticipated to expand steadily from 2025 to 2031 as healthcare providers increasingly emphasize early disease risk assessment, genetic testing, personalized medicine, advanced molecular diagnostics, and genomic-based healthcare solutions. Market Overview The Predictive And Presymptomatic Testing market was valued at US$ 6.23 billion in 2025...
0 Comments 0 Shares 81 Views 0 Reviews